Robust performance of domestic biz to help Torrent Pharma outperform peers

Chronic-heavy portfolio, pharma market recovery boost shares

A strong operating performance in the June quarter and a robust outlook for domestic operations pushed the Torrent Pharma stock up 9.3 per cent.

While revenues were broadly in line with estimates, its operating profit and margin performance stood out. Operating profit jumped 22 per cent and margins improved by 32 per cent, compared to estimates of 27 per cent.

Though there was little help from the top line with consolidated sales closing just 2 per cent higher, there were two factors that aided profitability. The first was the product mix in the domestic business, and the other was lower costs. Other